Evidence map›Paper›PMID 29020159›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests.

Wen-Yang Tsai, Han Ha Youn, Carlos Brites, Jih-Jin Tsai, Jasmine Tyson, Celia Pedroso, Jan Felix Drexler, Mars Stone, Graham Simmons, Michael P Busch and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Arbovirus surveillance in pregnant women in north-central Nigeria, 2019-2022.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 5 countries.

Wen-Yang TsaiDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu.
Han Ha YounDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu.
Carlos BritesLaboratory of Infection Research, School of Medicine, Federal University of Bahia, Salvador, Brazil.
Jih-Jin TsaiDivison of Infectious Diseases.
Jasmine TysonDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu.
Celia PedrosoLaboratory of Infection Research, School of Medicine, Federal University of Bahia, Salvador, Brazil.
Jan Felix DrexlerUniversity of Bonn Medical Centre, Institute of Virology.
Mars StoneBlood Systems Research Institute.
Graham SimmonsBlood Systems Research Institute.
Michael P BuschBlood Systems Research Institute.
Marion LanteriBlood Systems Research Institute.
Susan L StramerAmerican Red Cross Scientific Support Office, Gaithersburg, Maryland.
Angel BalmasedaNational Virology Laboratory, National Center for Diagnosis and Reference, Ministry of Health, Managua, Nicaragua.
Eva HarrisDivision of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley.
Wei-Kung WangDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu.
University of Hawaiʻi at Mānoa · USBlood Systems Research Institute · USUniversidade Federal da Bahia · BRUniversity of California, San Francisco · USAmerican Red Cross · USKaohsiung Medical University Chung-Ho Memorial Hospital · TWUniversity of Bonn · DEUniversity of California, Berkeley · US

Funding

Project 3 - Ex vivo immune profiling of dengue viruses and vaccinesU19AI118610 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FERNANDEZ-SESMA, ANA · 2015 to 2021
$46.6M
T Cell Responses Following DENV Natural Infections and Live-Attenuated Dengue Virus VaccinationP01AI106695 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI Daniela Weiskopf · 2015 to 2026
$34.1M
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)U19AI168631 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ana Fernandez-Sesma, Viviana A Simon · 2022 to 2026
$14.4M
Viral/Immune parameters of Dengue and WNV in donors: blood safety implicationsRC2HL101632 · NHLBI · VITALANT · PI BUSCH, MICHAEL PAUL · 2009 to 2010
$2.1M
Epidemiological, Clinical & Immunological Studies of Zika, dengue and chikungunyaR01AI099631 · NIAID · SUSTAINABLE SCIENCES INSTITUTE · PI BALMASEDA, ANGEL LAZARO · 2012 to 2021
$1.8M
Mature virus-like particles as a new strategy for dengue virus vaccinesR01AI110769 · NIAID · UNIVERSITY OF HAWAII AT MANOA · PI WANG, WEI-KUNG · 2014 to 2018
$1.5M
NHLBI NIH HHS RC2 HL101632NIAID NIH HHS P01 AI106695NIAID NIH HHS R01 AI099631NIAID NIH HHS R01 AI110769NIAID NIH HHS U19 AI118610NIAID NIH HHS U19 AI168631
6 · The paper itself

Abstract

backgroundThe explosive spread of Zika virus (ZIKV) and associated microcephaly present an urgent need for sensitive and specific serodiagnostic tests, particularly for pregnant women in dengue virus (DENV)-endemic regions. Recent reports of enhanced ZIKV replication by dengue-immune sera have raised concerns about the role of previous DENV infection on the risk and severity of microcephaly and other ZIKV complications.

methodsEnzyme-linked immunosorbent assays (ELISAs) based on ZIKV and DENV nonstructural protein 1 (NS1) were established to test acute, convalescent phase, and post-convalescent phase serum/plasma samples from reverse-transcription polymerase chain reaction-confirmed cases including 20 primary ZIKV, 25 ZIKV with previous DENV, 58 secondary DENV, and 16 primary DENV1 infections.

resultsZIKV-NS1 immunoglobulin M (IgM) and immunoglobulin G (IgG) ELISAs combined can detect ZIKV infection with a sensitivity of 95% and specificity of 66.7%. The ZIKV-NS1 IgG cross-reactivity by samples from secondary DENV infection cases ranged from 66.7% to 28.1% (within 1 month to 1-2 years post-illness, respectively). Addition of DENV1-NS1 IgG ELISA can distinguish primary ZIKV infection; the ratio of absorbance of ZIKV-NS1 to DENV1-NS1 IgG ELISA can distinguish ZIKV with previous DENV and secondary DENV infections with a sensitivity of 87.5% and specificity of 81.3%. These findings were supported by analysis of sequential samples.

conclusionsAn algorithm for ZIKV serodiagnosis based on 3 simple ELISAs is proposed to distinguish primary ZIKV, ZIKV with previous DENV, and secondary DENV infections; this could be applied to serodiagnosis for ZIKV, serosurveillance, and monitoring ZIKV infection during pregnancy to understand the epidemiology, pathogenesis, and complications of ZIKV in dengue-endemic regions.

Indexed as

AdultAntibodies, ViralCoinfectionCross ReactionsDengueDengue VirusEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulin GImmunoglobulin MSensitivity and SpecificitySerologic TestsViral Nonstructural ProteinsZika VirusZika Virus InfectionAntibodies, ViralImmunoglobulin GImmunoglobulin MNS1 protein, dengue-1 virusNS1 protein, zika virusViral Nonstructural Proteinscross-reactivitydengue virusnon-structural protein 1serological testZika virus

Identifiers

PMID29020159
PMCPMC5850648
OpenAlexW2741608607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.